Friday, September 4, 2026

BTC $81,143 ▲ 4.09%

NewsLive Wire Politics World Markets Digital Assets Technology Sports

FranchisesThe Brief The Big Read The Breakdown Crypto Culture

MoreDeFi & On-Chain U.S. Equities Macro & Rates Research

LIVE

BTC$81,143+4.09%ETH$2,520+4.70%SOL$103.97+3.22%XRP$1.45+5.64%LINK$12.01+6.45%ADA$0.221+6.53%S&P 5007,748+1.06%Nasdaq26,584+1.40%Dow53,686+1.18%RUT2,968+0.51%TNX4.76%−0.71%TYX5.24%−0.46%FVX4.51%−0.94%IRX3.74%−0.85%VIX14.19−0.91%GOLD$4,512.40−0.61%SILVER$67.46−0.37%OIL$90.42−0.96%DXY99.06+0.15%NVDA$228.45+1.80%AAPL$328.21+1.00%TSLA$376.37+5.42%META$610.68+3.01%MSFT$510.12+2.68%AMZN$258.90+1.54%GOOGL$342.48+1.59%Fear & Greed74 — GreedBTC$81,143+4.09%ETH$2,520+4.70%SOL$103.97+3.22%XRP$1.45+5.64%LINK$12.01+6.45%ADA$0.221+6.53%S&P 5007,748+1.06%Nasdaq26,584+1.40%Dow53,686+1.18%RUT2,968+0.51%TNX4.76%−0.71%TYX5.24%−0.46%FVX4.51%−0.94%IRX3.74%−0.85%VIX14.19−0.91%GOLD$4,512.40−0.61%SILVER$67.46−0.37%OIL$90.42−0.96%DXY99.06+0.15%NVDA$228.45+1.80%AAPL$328.21+1.00%TSLA$376.37+5.42%META$610.68+3.01%MSFT$510.12+2.68%AMZN$258.90+1.54%GOOGL$342.48+1.59%Fear & Greed74 — Greed

Tag

retatrutide

1 article

U.S. Equities42d ago

Eli Lilly's Retatrutide FDA Bid Targets $25B Peak Sales in $100B Obesity Market

Lilly's triple-receptor weight-loss drug retatrutide heads to FDA with a 24 percent efficacy edge over rivals and a $1,200 price target from JPMorgan.